Figure Legend
Figure: Effective redeployment of existing medicines requires
explicit consideration of indication-specific factors relating to
differences in potency, plasma and tissue pharmacokinetics (PK), safety,
formulation, posology and barriers to equitable deployment across
relevant populations and country contexts.